How should active oral bleeding be managed?

Management of Active Oral Bleeding

Immediately apply local therapy with manual compression as the first-line intervention for active oral bleeding, regardless of anticoagulation status. 1

Initial Assessment and Immediate Actions

Determine Bleeding Severity

First, classify whether the bleeding is major or non-major based on: 1

• Critical site involvement (though oral cavity is typically not considered a critical site)
• Hemodynamic instability
• Hemoglobin decrease ≥2 g/dL or transfusion of ≥2 units RBCs

Immediate Management Steps

For patients NOT on anticoagulation:

• Apply direct manual compression to the bleeding site 1
• Use local hemostatic agents such as tranexamic acid-soaked gauze 2
• Consider collagen fleece placement at the bleeding site 3
• If compression fails, place sutures to achieve hemostasis 2

For patients on oral anticoagulants (OACs):

If bleeding is non-major (most oral bleeding):

• Stop the oral anticoagulant temporarily 1
• Apply local therapy/manual compression 1
• If on warfarin (VKA), consider 2-5 mg PO/IV vitamin K 1
• If on DOACs (apixaban, rivaroxaban, dabigatran, edoxaban), do NOT administer reversal agents for non-major bleeds 1
• Stop antiplatelet agents if applicable 1
• Provide supportive care and volume resuscitation 1

If bleeding is major (rare for oral bleeding unless life-threatening):

• Stop OAC and all antiplatelet agents 1
• If on warfarin, give 5-10 mg IV vitamin K 1
• Apply local therapy/manual compression 1
• Provide supportive care and volume resuscitation 1
• Consider reversal agents only if life-threatening 1

Advanced Local Hemostatic Measures

When simple compression is insufficient: 2

1. Tranexamic acid-soaked swabs for local compression
2. Suturing the bleeding site
3. Tabotamp® (local hemostypticum) placed directly on bleeding to increase platelet aggregation
4. Floseal® (human thrombin) for rapid, definitive hemostasis in severe cases
5. Acrylic splint placement over the wound site 3

Critical Pitfalls and Caveats

Anticoagulation considerations:

• Patients on rivaroxaban have an 11.5% postoperative bleeding rate versus 0.7% in non-anticoagulated patients, but all bleeding events are manageable with local measures 4
• Patients on warfarin with INR 2.44 (mean) have a 7.4% bleeding rate after oral surgery, with only 2.4% requiring hospital treatment, and local measures are sufficient in nearly all cases 3
• Never routinely reverse DOACs for non-major oral bleeding as local measures are adequate 1

Timing considerations:

• Most postoperative oral bleeding occurs within the first postoperative week 4
• Close observation for up to 1 week is advisable after procedures in anticoagulated patients 4

Assessment of Contributing Factors

Evaluate and manage comorbidities that worsen bleeding: 1

• Thrombocytopenia
• Uremia
• Liver disease
• Verify appropriate OAC dosing if patient remains on therapy

When to Consider Procedural/Surgical Management

If local measures fail to control bleeding: 1

• Consider surgical or procedural management of the bleeding site
• Consult appropriate specialists (oral surgery, ENT)
• Reassess for unidentified bleeding sources

Restarting Anticoagulation

Once bleeding is controlled, restart anticoagulation unless: 1

• Patient is at high risk of rebleeding
• Source of bleed has not been identified
• Surgical procedures are planned
• Patient declines to restart therapy

For most oral bleeding episodes with identified and treated sources, anticoagulation can be restarted once hemostasis is achieved. 1